₹411.85
▲ +2.7 +0.66%
As of 27 Jul 2026 · delayed
NSE Listed
Syngene International Ltd. (SYNGENE)
Volume: 5,30,727Avg Vol 1W: 8,91,295Avg Vol 1M: 9,34,233.9552W Range:₹380₹728.6
Key Ratios
Checked 1d agoMarket Cap₹16,415 Cr
Current Price₹411.85
Previous Close₹409.15
High / Low (52w)₹728.6 / ₹380
Volume5,30,727
Avg Vol (1W)8,91,295
Avg Vol (1M)9,34,233.95
Stock P/E62.43
Book Value₹115.25
Dividend Yield—
ROE10.6%
ROA—
Revenue (TTM)₹3,714 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹11.63
P/B6.3
Debt / Equity0.07
50 DMA₹434.6
200 DMA₹508.28
Day change+0.66%
Price Chart
₹411.85▼ 42.11% · 1Y
2025-07-292026-07-27
20-day avg volume: 9.3L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 62.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹790 Cr | ₹891 Cr | ₹944 Cr | ₹1,018 Cr | ₹875 Cr | ₹911 Cr | ₹917 Cr | ₹1,037 Cr |
| EBITDA | ₹81 Cr | ₹150 Cr | ₹193 Cr | ₹256 Cr | ₹113 Cr | ₹98 Cr | ₹111 Cr | ₹214 Cr |
| Net Profit | ₹76 Cr | ₹106 Cr | ₹131 Cr | ₹183 Cr | ₹87 Cr | ₹67 Cr | ₹15 Cr | ₹148 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹877 Cr | ₹3,714 Cr | ₹948 Cr | ₹799 Cr | ₹830 Cr | ₹834 Cr | ₹960 Cr | ₹3,809 Cr |
| EBITDA | ₹177 Cr | ₹681 Cr | ₹239 Cr | ₹90 Cr | ₹92 Cr | ₹102 Cr | ₹211 Cr | ₹536 Cr |
| Net Profit | ₹123 Cr | ₹496 Cr | ₹174 Cr | ₹74 Cr | ₹66 Cr | ₹17 Cr | ₹148 Cr | ₹317 Cr |
| EPS | — | 12.34 | — | — | — | — | — | 7.87 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,704 Cr | ₹4,163 Cr | ₹4,883 Cr | ₹5,564 Cr | ₹5,831 Cr | ₹6,152 Cr | ₹6,796 Cr | ₹7,055 Cr |
| Total Liabilities | ₹1,735 Cr | ₹1,987 Cr | ₹2,062 Cr | ₹2,266 Cr | ₹2,213 Cr | ₹1,894 Cr | ₹2,069 Cr | ₹2,216 Cr |
| Equity | ₹1,968 Cr | ₹2,176 Cr | ₹2,821 Cr | ₹3,298 Cr | ₹3,618 Cr | ₹4,258 Cr | ₹4,727 Cr | ₹4,839 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹727 Cr | ₹784 Cr | ₹785 Cr | ₹686 Cr | ₹960 Cr | ₹1,167 Cr | ₹1,283 Cr | ₹985 Cr |
| Investing | ₹-646 Cr | ₹-428 Cr | ₹-628 Cr | ₹-611 Cr | ₹-656 Cr | ₹-496 Cr | ₹-745 Cr | ₹-860 Cr |
| Financing | ₹-72 Cr | ₹-225 Cr | ₹58 Cr | ₹-31 Cr | ₹-342 Cr | ₹-551 Cr | ₹-142 Cr | ₹-215 Cr |
| Free Cash Flow | ₹727 Cr | ₹784 Cr | ₹785 Cr | ₹686 Cr | ₹960 Cr | ₹1,167 Cr | ₹1,283 Cr | ₹985 Cr |
Shareholding
Promoter 52.59% Institutions 39.83% Public 7.58%
Efficiency & Working Capital
ROCE9.7%
Interest Coverage10.9
Dividend Payout—
Debtor Days50 d
Inventory Days14 d
Payable Days34 d
Cash Conversion Cycle30 d
Working Capital Days63 d
Shareholding Details
As of 2026-06-30
Promoter52.6%
FII11.8%
DII28%
Institutions39.8%
Public7.6%
Promoter Pledge0%
No. of Shareholders1,42,277
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.8% | 54.8% | 54.8% | 54.7% | 54.7% | 52.7% | 52.7% | 52.7% | 52.7% | 52.7% | 52.7% | 52.6% |
| FIIs | 23.6% | 21.2% | 20.9% | 20.6% | 20.7% | 20.6% | 19.5% | 16.5% | 16.3% | 15% | 13.9% | 11.8% |
| DIIs | 9.9% | 13.1% | 15.8% | 16.8% | 17.5% | 19.5% | 21.5% | 24% | 24.6% | 25.8% | 26.4% | 28% |
| Public | 11.7% | 10.9% | 8.5% | 7.8% | 7.1% | 7.1% | 6.3% | 6.8% | 6.4% | 6.5% | 7% | 7.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,25,992 | 1,21,880 | 1,15,850 | 1,20,018 | 1,07,338 | 1,28,806 | 1,25,090 | 1,42,310 | 1,36,061 | 1,31,750 | 1,35,605 | 1,42,277 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Biocon Limited | Shareholding of Promoter and Promoter Group | 52.3% | 21.12 Cr |
| Nippon Life India Trustee Ltd- A/c Nippon India Fo | Public Shareholding | 7.7% | 3.12 Cr |
| Icici Prudential Nifty Smallcap 250 Etf | Public Shareholding | 5.3% | 2.14 Cr |
| Dsp Nifty Smallcap 250 Index Fund | Public Shareholding | 4.6% | 1.86 Cr |
| Government Of Singapore | Public Shareholding | 2.1% | 86,06,745 |
| Sbi Nifty Smallcap 250 Index Fund | Public Shareholding | 2% | 78,78,170 |
| Mirae Asset Nifty 500 Healthcare Etf | Public Shareholding | 1.9% | 74,53,764 |
| Life Insurance Corporation Of India | Public Shareholding | 1.8% | 71,83,419 |
| Hsbc Mutual Fund - Hsbc Midcap Fund | Public Shareholding | 1.6% | 62,38,897 |
| Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar) | Shareholding of Promoter and Promoter Group | 0.3% | 10,53,633 |
| Kiran Mazumdar Shaw | Shareholding of Promoter and Promoter Group | 0% | 21,964 |
| Ravi Rasendra Mazumdar | Shareholding of Promoter and Promoter Group | 0% | 8,806 |
| Biocon Research Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dev Mazumdar | Shareholding of Promoter and Promoter Group | 0% | 13,686 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Kiran Mazumdar Shaw | Executive Chairman | 2026 |
| Peter John Bains | Managing Director & CEO | 2026 |
| Catherine Patricia Rosenberg | Non-Exec & Non-Independent Dir | 2026 |
| Vinita Bali | Non-Exec & Non-Independent Dir | 2026 |
| Kush Parmar | Independent Non Exe. Director | 2026 |
| Sharmila Karve | Lead Independent Non Executive Director | 2026 |
| Nilanjan Roy | Independent Non Exe. Director | 2026 |
| Manja Boerman | Independent Non Exe. Director | 2026 |
| Sanjaya Singh | Independent Non Exe. Director | 2026 |
| Suresh Narayanan | Independent Non Exe. Director | 2026 |
| Arun Suresh Chandavarkar | Independent Director | 2026 |
| Chethan Yogesh | Company Sec. & Compli. Officer | 2026 |
| Vijaya Chandru | Independent Director | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Providing contract research and man | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹136 Cr | 4% |
| United States of America | ₹2,198 Cr | 64.2% |
| Europe | ₹952 Cr | 27.8% |
| Rest of the World | ₹139 Cr | 4.1% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 500 | 403 | 403 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-29 | Board Meetings | — |
| dividend | 2026-06-25 | ₹1.25 (12.5%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 281 | 0 | 0 | 33 | 230 | 597 |
| 2026 | 257 | 0 | 0 | 33 | 21 | 336 |
| 2026 | 24 | 0 | 0 | 0 | 209 | 261 |
Insider / Designated-Person Trades
30 recent disclosure(s)
ANJAN CHAKRABARTIDisposal · 6,190
ANJAN CHAKRABARTIDisposal · 27,200
ANJAN CHAKRABARTIAcquisition · 58,390
BIOCON LIMITEDDisposal · 80,00,000
DEEPAK VENKATRAMANDisposal · 600
DEEPAK VENKATRAMANDisposal · 600
Substantial Acquisitions (SAST)
2 disclosure(s)
Market08/05/2025 · 3,61,572
Market10/12/2024 · 80,00,000
Company Information
Incorporated1993
ChairmanKiran Mazumdar Shaw
AuditorB S R & Co LLP
Investor Email[email protected]; Mayank.Verma@syngeneintl
📍 Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Swelect Energy Systems Ltd.Swiggy LimitedSterling & Wilson Renewable Energy Ltd.Sylvan Plyboard (India) LimitedSymphony LimitedSyncom Formulations (India) Ltd.Synoptics Technologies LimitedSyrma SGS Technology Ltd.Systango Technologies Ltd.Systematix Corporate Services Ltd.TaaL Tech Ltd.TAC Infosec LimitedAll “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search